Director/PDMR Shareholding

RNS Number : 5561C

Smith & Nephew Plc

23 February 2022

 

SMITH & NEPHEW PLC

23 February 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.

Smith & Nephew Global Share Plan 2010 (Performance Share Awards):

The following relates to individuals included in the below notification:

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Lapse of a Performance Share Award granted on 7 March 2019 under the Smith & Nephew Global Share Plan 2010
Date of Transaction	2022 - 02 - 22
Place of Transaction	Lapse took place outside a trading venue

Name of PDMR (Position)	Number of ordinary shares under award granted on 07/03/2019 (shown at maximum)	Number of ordinary shares lapsed under award (shown at maximum)	Number of ordinary shares outstanding under award (shown at maximum)
Helen Barraclough (Group General Counsel)	12,054	12,054	0
Bradley Cannon ( President, Orthopaedics, Sports Medicine & ENT and Americas)	30,784	30,784	0
Phil Cowdy (Chief Business Development & Corporate Affairs Officer)	22,564	22,564	0
Simon Fraser (President, Advanced Wound Management & Global Commercial Operations)	27,166	27,166	0
Elga Lohler (Chief HR Officer)	26,722	26,722	0
Vasant Padmanabhan (President, Research & Development)	26,382	26,382	0
Susan Swabey (Company Secretary)	9,784	9,784	0

Notes:

(i)  Following completion of the performance measurement period, these awards lapsed in full on 22 February 2022.

(ii)  Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 7 March 2022.

This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END

 

 

DSHFIFETFLIVFIF